Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

201
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
201
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

380
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
380
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

287
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
287

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Anifrolumab use in pregnancy: maternal and neonatal outcomes in patients with systemic lupus erythematosus.

EULAR rheumatology open·2026
Same author

Retiring rusty myths around intravenous iron.

HemaSphere·2026
Same author

A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders.

Expert review of hematology·2026
Same author

Navigating uncharted waters: obstetric outcomes and antibiotic management in patients with neobladders and neurogenic bladders.

American journal of obstetrics & gynecology MFM·2026
Same author

Spontaneous Heparin-Induced Thrombocytopenia after Total Hip Arthroplasty.

The New England journal of medicine·2026
Same author

Economic burden of non-transfusion-dependent thalassemia in the United States.

Journal of medical economics·2026
Same journal

The Natural Mutation Arg221aTrp in Human α-Thrombin Abrogates Physiological Na<sup>+</sup> Binding and Preferentially Hinders the Protease Anticoagulant Functions.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

A historical review of the biological, semantic and clinical aspects of aspirin resistance.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Association between Thrombus Neutrophil Extracellular Traps Content and Ischemic Stroke Recurrence.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Peptide-Mediated Inhibition of Surface-Initiated Thrombogenesis.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Physiological Anticoagulant Deficiencies: Pathogenesis, Diagnosis, and Clinical Implications.

Journal of thrombosis and haemostasis : JTH·2026
查看所有相关文章

相关实验视频

Updated: Jan 16, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.1K

管理抗凝血周周部分.

Arielle L Langer1, Brandon Togioka2, Nicole A Smith3

  • 1Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Women's Health, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Journal of thrombosis and haemostasis : JTH
|September 27, 2025
PubMed
概括
此摘要是机器生成的。

在怀孕期间管理抗凝血需要仔细规划,以平衡血栓形成风险和产后出血问题. 涉及多名专家的个性化分娩策略确保了孕妇服用抗凝药的安全结果.

关键词:
抗凝固剂是一种抗凝固剂.周边的时间是周边的时间.怀孕 怀孕 怀孕 怀孕 怀孕静脉血栓塞栓症是一种静脉血栓塞栓.

更多相关视频

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.9K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.7K

相关实验视频

Last Updated: Jan 16, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.1K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.9K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.7K

科学领域:

  • 产科和妇科 产科和妇科
  • 血液学 血液学 血液学
  • 麻醉学 麻醉学

背景情况:

  • 由于血栓形成风险增加,在怀孕期间经常使用抗凝药.
  • 产后抗凝管理是复杂的,需要在治疗效益和出血风险之间保持平衡.
  • 对于接受抗凝药的患者,神经轴麻醉的可用性可能是有限的.

研究的目的:

  • 概述在服用抗凝药的孕妇中计划分娩的关键考虑因素.
  • 强调多学科合作对于安全的周周抗凝管理的重要性.
  • 对静脉血栓栓塞的产后抗凝策略进行审查.

主要方法:

  • 审查当前的文献和临床指导方针关于周周结血抗凝剂.
  • 讨论影响分娩决策的因素,包括剂量,分娩方式和麻醉.
  • 考虑患者的偏好和特定的临床情景.

主要成果:

  • 输送计划包括评估预防性与治疗性剂量,输送方式和时间.
  • 患者特定的因素,如神经轴麻醉的指示和患者的价值至关重要.
  • 在分娩前,可能需要过渡到不同的抗凝方法 (例如,肝素输注).

结论:

  • 最佳的周产期抗凝剂需要血栓专家,产科医生和麻醉师之间的产前合作.
  • 个性化分娩计划对于减轻血栓和出血风险至关重要,同时尊重患者的偏好.
  • 在这种高风险时期,坚持产后抗凝药非常重要.